As expected, positive control analyses showed lower risks of major adverse cardiovascular events and major adverse kidney events among GLP-1 RA initiators relative to DPP-4i initiators, whereas negative control outcomes (glaucoma and bone fracture) did not differ between groups ( Supplementary Table 2 )
If you experience blurred vision, dizziness, or drowsiness due to extremely low or high blood sugar, do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can do them safely
If you do not feel an immediate, profound change in your body within the first 72 hours, do not be discouraged
Researchers interested in learning more about retatrutide research peptides can explore our Retatrutide Research Knowledge Hub , which provides educational resources covering peptide structure, storage practices, and laboratory research topics
By simultaneously activating GLP-1, GIP, and glucagon receptors, it allows researchers to investigate receptor cross-talk, intracellular cascades, and their role in glucose regulation, lipid metabolism, and energy homeostasis